MediaMedic

Omission of surgery in early breast cancer: Are we ready for a paradigm shift?

By Mourabit Halima 2025.05.19

In a recent ESSO Research Academy survey led by Carmela Caballero and co-authored by Prof. Isabel T. Rubio, Prof. Evandro de Azambuja, and Prof. Stuart A. McIntosh, both clinicians and…

Advancing precision oncology with metabolomics and machine learning

By Yin, Jiale 2025.05.19

A new study led by Dr. Rafael Nambo Venegas and colleagues, published in Metabolomics (Feb 2025), presents a high-accuracy predictive model for forecasting response to neoadjuvant therapy in breast cancer…

Risk-based breast cancer screening: A shift toward personalized prevention

By Mourabit Halima 2025.05.19

In a recent study published in December 2024, Professor Isabel Rubio and her colleagues critically examined the limitations of current age-based breast cancer screening programs, which remain standard in most…

Temocillin in the Spotlight: Dr. Francesco Cogliati Dezza on Tackling Antimicrobial Resistance

By Mourabit Halima 2025.05.14

At ESCMID Global 2025, Infectious Disease Frontier interviewed Dr. Francesco Cogliati Dezza to explore the renewed clinical relevance of temocillin. With resistance to broad-spectrum antibiotics on the rise, temocillin is…

Professor Li Zhang’s Team Publishes Again in Nature Medicine

By Mourabit Halima 2025.05.12

On April 10, 2025, a research team led by Professor Li Zhang and Professor Wenfeng Fang from Sun Yat-sen University Cancer Center published a significant study in the world-renowned journal…

Mok Talk | Lung Cancer Leadership, Innovation, and the Power of Collaboration

By Peng Longmei 2025.05.09

In this special episode of Mok Talk, Professor Tony Mok (The Chinese University of Hong Kong) sits down with three rising oncology experts Professor Yang Xia (Zhejiang University), Professor Wenhua…

Temocillin in the Spotlight: Dr. Francesco Cogliati Dezza on Tackling Antimicrobial Resistance

By Mourabit Halima 2025.05.09

At ESCMID Global 2025, Infectious Disease Frontier sat down with Dr. Francesco Cogliati Dezza to discuss the renewed clinical relevance of temocillin. As resistance to broad-spectrum antibiotics continues to rise,…

Advancing the Diagnosis and Prevention of Congenital CMV: Insights from Dr. Marianne Leruez-Ville

By Dingming Xue 2025.05.08

At ESCMID Global 2025, one of the world’s leading forums for infectious disease and clinical microbiology, congenital cytomegalovirus (CMV) took center stage as experts explored new avenues in screening, prevention,…

Temocillin and the Search for Carbapenem Alternatives: A Conversation with Dr. Francesco Cogliati Dezza at ESCMID Global 2025

By Dingming Xue 2025.05.08

At ESCMID Global 2025, antimicrobial resistance stood out as one of the most pressing topics. As carbapenem resistance rises to alarming levels worldwide, the medical community is urgently seeking viable…

Prof. Lin Visits MGH | Talk with Prof. Lori Wirth on Targeted Therapy for Advanced Thyroid Cancer

By Mourabit Halima 2025.05.08

Join us for an exclusive conversation between Prof. Yansong Lin of Peking Union Medical College Hospital and Prof. Lori Wirth at Massachusetts General Hospital. In this special academic exchange, the…

CSCO Guidelines Conference 2026 | Professor Jun Zhu: Redefining the Future of Lymphoma Care—Guideline Updates Shaping a “China Solution”

CSCO Guidelines Conference 2026 | Professor Jun Ma: Illuminating Standardized Care Through Guidelines—Driving High-Quality Development of Oncology Practice in China

EBMT Global Perspective | Professor Donal McLornan: Defining Remission Criteria and Optimizing Novel Combination Strategies for Bone Marrow Transplantation in MDS/MPN Overlap Syndromes

EBMT President Professor Ibrahim Yakoub-Agha: A Global Vision for the Future of Therapy—Strengthening Collaboration, Empowering Data, and Standardizing Cellular Therapies

EBMT Global Perspective | Professor Francesca Ferrua: Breakthroughs in Autologous Hematopoietic Stem Cell Gene Therapy for WAS—From Concept to Clinical Practice

EBMT Global Perspective | Professor Annalisa Ruggeri: Cord Blood Transplantation—From Established Platform to Frontier Therapeutic Modality

Professor Yuankai Shi: Thirty-Five Years of Iterative Innovation—Lymphoma Leading China’s Modernization in Oncology Drug Therapy | 2026 CACA Western Integrative Oncology Conference

Annual Meeting of the Hematology Branch, CPAM | Professor Yajing Xu: Long-Term Follow-Up Management After Hematopoietic Stem Cell Transplantation—From Digital Solutions to Primary Care Collaboration

AACR China Voice | Qilu Pharmaceutical Showcases Multiple Innovative Breakthroughs at AACR, Driving Global Advances in Oncology Through Originative Innovation

AACR China Voice | Professor Tao Zhu: First-in-Human Study of CLDN6 ADC QLS5132 Demonstrates Promising Efficacy and Safety, Opening New Directions for Platinum-Resistant Ovarian Cancer

CSCO Guidelines Conference 2026 | Professor Jun Zhu: Redefining the Future of Lymphoma Care—Guideline Updates Shaping a “China Solution”

CSCO Guidelines Conference 2026 | Professor Jun Ma: Illuminating Standardized Care Through Guidelines—Driving High-Quality Development of Oncology Practice in China

Omission of surgery in early breast cancer: Are we ready for a paradigm shift?

Advancing precision oncology with metabolomics and machine learning

Risk-based breast cancer screening: A shift toward personalized prevention

Temocillin in the Spotlight: Dr. Francesco Cogliati Dezza on Tackling Antimicrobial Resistance

Professor Li Zhang’s Team Publishes Again in Nature Medicine

Mok Talk | Lung Cancer Leadership, Innovation, and the Power of Collaboration

Temocillin in the Spotlight: Dr. Francesco Cogliati Dezza on Tackling Antimicrobial Resistance

Advancing the Diagnosis and Prevention of Congenital CMV: Insights from Dr. Marianne Leruez-Ville

Temocillin and the Search for Carbapenem Alternatives: A Conversation with Dr. Francesco Cogliati Dezza at ESCMID Global 2025

Prof. Lin Visits MGH | Talk with Prof. Lori Wirth on Targeted Therapy for Advanced Thyroid Cancer

CSCO Guidelines Conference 2026 | Professor Jun Zhu: Redefining the Future of Lymphoma Care—Guideline Updates Shaping a “China Solution”

CSCO Guidelines Conference 2026 | Professor Jun Ma: Illuminating Standardized Care Through Guidelines—Driving High-Quality Development of Oncology Practice in China

EBMT Global Perspective | Professor Donal McLornan: Defining Remission Criteria and Optimizing Novel Combination Strategies for Bone Marrow Transplantation in MDS/MPN Overlap Syndromes

EBMT President Professor Ibrahim Yakoub-Agha: A Global Vision for the Future of Therapy—Strengthening Collaboration, Empowering Data, and Standardizing Cellular Therapies

Welcome to Mediamedic 👋
It’s nice to meet you.

Welcome to Mediamedic 👋It’s nice to meet you.

Welcome to Mediamedic 👋
It’s nice to meet you.